Cell-Free DNA - Market Research, Industry Trends, Market Share

Published: 04/12/2017
Pages: 178
Full Study Price: US$ 3,500

Cell-Free DNA (cfDNA) Markets explores the use of cell-free DNA (cfDNA) and the mounting recognition it has enjoyed in recent years. Due to its potential to revolutionize the diagnosis and treatment of several conditions, cfDNA and “liquid biopsies” of other analytes is now representative of major application potential in healthcare. The main areas where cdDNA analysis has turned into a major application include: non-invase prenatal testing (NIPT); oncology; circulating tumor DNA (ctDNA); and transplantation, donor-derived cell-free DNA (ddcfDNA).

Cell-Free DNA (cfDNA) Markets offers a comprehensive overview of the market for cfDNA analysis instruments, consumables, kits, and related software. This includes the sample preparation products and equipment as well as the next generation sequencing (NGS) and digital polymerase chain reaction (dPCR) systems that are used for detection. This report provides complete information for the cfDNA market and offers market estimates and forecasts through to 2021. Also provided are the data relevant to cfDNA analysis products, which comment not only on reagents, consumables, kits, systems, software, and services, but also on the oncology of cfDNA products, cfDNA transplantation diagnostics, and other products employing cfDNA.

Our Simple Buying Process

Choose License and Add
This Report To Your Cart.

Register, Checkout
and Verify Payment.

Receive Notification When
Your Report Is Available.

Table Of Contents

  • Executive Summary
    • NIPT, Oncology Leading Market Forward
    • Sensitivity Benefits of dPCR, qPCR, NGS
    • Challenges, Biological and Technologies Limitations
    • Scope and Methodology
  • Introduction
    • NIPT Companies, Others Shifting Strategies to Cancer
    • Expanding Clinical Adoption Sustains High Growth
    • Government Initiatives -- Cancer Moonshot, Blood Profiling Atlas
    • Mergers, Acquisitions, Equity Investments Increasing
    • China Becoming Major Player in Market
    • Personalized, Proactive Medicine Gaining Momentum
    • Expected Sequencer Platforms Stalled or Cancelled
    • Significant Efforts in Automation, Miniaturization
    • Regulatory Situation Unclear But Evolving Somewhat
  • cfDNA Analysis Products
    • cfDNA Reagents, Consumables, and Kits
      • Table cfDNA Reagents, Consumables, and Kits
    • cfDNA Systems and Software
      • Table cfDNA Systems and Software
    • cfDNA NIPT Products and Services
      • Table cfDNA NIPT Products and Services
    • cfDNA in Oncology, Transplantation and Other Diseases
      • Table Oncology cfDNA Products
      • Table cfDNA Transplantation Diagnostics
    • cfDNA Other Products
      • Table cfDNA Other Products
    • Recent Product/ Service Introductions
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
  • Market Analysis
    • Revenues Forecast
      • Table Cost of Sequencing a Genome
    • Market Size and Forecast
      • Table Market for cfDNA, 2015-2021
      • Table cfDNA Market, 2015-2021 ($M)
      • Table Growth Rate for cfDNA Market, 2015-2021
      • Table Growth Rate in cfDNA Market, 2016-2020
    • cfDNA Clinical Diagnostics Market
      • Table cfDNA Clinical Diagnostics Market, 2015-2021 ($M)
      • Table cfDNA Clinical Diagnostics Market Growth Rate, 2015-2021
    • cfDNA Market by Region
      • Table cfDNA Market by Region, 2015 (N. America, Europe, Asia-Pacific & ROW)
      • Table cfDNA Market by Region, 2015 (%) (N. America, Europe, Asia-Pacific & ROW)
    • Revenues by Product Type
      • Table cfDNA Instruments and Consumables Revenues by Product Type, 2015 (Consumables, Systems/hardware, Services)
      • Table Breakout of cfDNA Market by Type (Consumables, Systems/hardware, Services)
    • Illumina Sequencing Revenues as Indicator
      • Table Illumina Quarterly Sequencing Revenues (2012-2016)
      • Table Illumina Quarterly Consumables Revenues (2012-2016)
      • Table Illumina Annual Consumables Revenues (2012-2015)
      • Table Illumina Consumables Growth Rates (2013-2015)
  • cfDNA Instruments and Consumables Competitive Analysis
    • Introduction
    • cfDNA Instruments and Consumables Market Shares
      • Table Market Shares by Company of the cfDNA Analysis Instruments, Consumables, and Software Market, 2015
      • Table cfDNA Instruments and Consumables Market Share by Company, 2015 (%)
  • Intellectual Property and Litigation
    • Sequenom, Several NIPT Companies Fighting
    • Ariosa Diagnostics (Roche) Files Suit Against Sequenom
    • Natera Sues Sequenom; Sequenom Sues Natera
    • Verinata Health and Stanford File Against Sequenom
    • Verinata Health Against Ariosa and LabCorp
    • Illumina Sues Ariosa Diagnostics for NIPT Test
    • Illumina Sues Premaitha Health for NIPT Test
    • Illumina Sues Premaitha and Ariosa Partners
    • Sequenom and Illumina Settle and Pool Patents
    • Sequenom Petitions Supreme Court
    • Illumina Sues Qiagen for GeneReader System
    • llumina's Conflicts with Oxford Nanopore
    • Enzo Biochem Brings Suit Against Numerous Companies
    • 454 (Roche) Sues Ion Torrent (Thermo Fisher)
    • RainDance Technologies Sues 10X Genomics
    • 10X Genomics' Dispute with Bio-Rad
    • Sequenom Shareholder Sues Over Price "Capping"
    • Helicos' Patent Infringement Suit Against PacBio, Life Technologies, and Illumina
    • Illumina's Two Lawsuits Against Complete Genomics for Infringement
    • Life Technologies and Illumina Dispute Over Amplification on Solid Surfaces
    • Enzo Biochem Disputes Sequencing Patents
    • LabCorp's Esoterix Sues Life Technologies
    • Genetic Technologies Sues Several Firms for Infringement of Haplotype Determination Technique
  • cfDNA Analysis Market Deals
    • The Significant Collaborations
      • Table cfDNA Analysis Market Deals
  • cfDNA Instruments and Consumables Market Corporate Profiles
    • Agilent Technologies
    • Bio-Rad
    • F. Hoffmann-La Roche AG
    • Fluidigm
    • Illumina
    • Qiagen
    • RainDance Technologies
    • Thermo Fisher Scientific
  • Challenges and Strategic Recommendations
    • Challenges
    • Strategic Recommendations